Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ChromaTwist is a UK-based private company and University of Birmingham spinout developing large Stokes shift organic fluorescent dyes and fluorophores for bio-imaging and bio-sensing applications. Its platform uses patented, modular, and scalable chemistry to create UV- and blue-excited probes with tunable emission across the visible spectrum. The company focuses on research-use and diagnostic-enabling applications including flow cytometry, multiphoton microscopy, and related imaging workflows rather than therapeutic drug development. ChromaTwist also sells chemical precursors and fluorescent materials and has established a supply agreement with Merck (Sigma-Aldrich) for distribution of certain dyes. Overall, it is best characterized as a life science tools and advanced materials company serving biomedical research and diagnostics markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ChromaTwist.